Drug Discovery and Development Analysis & Statistics, October 2014

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

  • All
    • GBI Research

data types

You might be interested in: clinical trial, drug discovery, drug development, more »

1-30 of 40 reports

Purchase Reports From Reputable Market Research Publishers

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

  • $ 2 995
  • Industry report
  • July 2014
  • by GBI Research

Adaptive Licensing (AL) is a flexible approach to drug development and regulation, with two live pilot schemes accepted by the European Medicines Agency (EMA). The system acknowledges that levels of uncertainty ...

  • Industries : Drug Discovery and Development
  • Countries : Europe
Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth

Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth

  • $ 3 500
  • Industry report
  • June 2013
  • by GBI Research

Summary GBI Research, a leading business intelligence provider, has released its latest research report ?Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products ...

  • Industries : Drug Discovery and Development
  • Countries : World
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes

Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes

  • $ 3 500
  • Industry report
  • November 2012
  • by GBI Research

Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes Summary GBI Research's new report, ?Biomarkers in Drug Discovery - Integration ...

  • Industries : Drug Discovery and Development
  • Countries : World
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation

Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation

  • $ 3 500
  • Industry report
  • November 2012
  • by GBI Research

Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation Summary GBI Research, a leading ...

  • Industries : Drug Discovery and Development
  • Countries : Asia
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market

  • $ 3 500
  • Industry report
  • September 2012
  • by GBI Research

Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market Summary GBI Research's new report, ?Accelerating Drugs to Market - Despite ...

  • Industries : Drug Discovery and Development
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

  • $ 3 500
  • Industry report
  • August 2012
  • by GBI Research

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Summary GBI Research, leading business intelligence provider has released its latest research ...

  • Industries : Drug Discovery and Development
  • Countries : India, China, World
e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

  • $ 3 500
  • Industry report
  • July 2012
  • by GBI Research

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies Summary GBI Research, ...

  • Industries : Drug Discovery and Development
  • Countries : World
Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development

Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development

  • $ 3 500
  • Industry report
  • July 2012
  • by GBI Research

Summary GBI Research, leading business intelligence provider, has released its latest research report, entitled ?Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development". Ove ...

  • Industries : Drug Discovery and Development
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles Summary GBI Research in its report ?Endpoints - ...

  • Industries : Drug Discovery and Development
  • Countries : World
Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue

Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue Summary GBI Research's new report, ?Emerging Pharmaceutical ...

  • Industries : Drug Discovery and Development
  • Countries : Argentina
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge

  • $ 3 500
  • Industry report
  • May 2012
  • by GBI Research

Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

  • $ 3 500
  • Industry report
  • April 2012
  • by GBI Research

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs Summary GBI Research, the leading business ...

  • Industries : Drug Discovery and Development
  • Countries : World, India
Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success

Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success

  • $ 3 500
  • Industry report
  • January 2012
  • by GBI Research

Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success Summary GBI Research, the leading business intelligence ...

  • Industries : Drug Discovery and Development
  • Countries : World
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

  • $ 3 500
  • Industry report
  • January 2012
  • by GBI Research

Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Drug Discovery and Development
  • Countries : World
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US

Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Emerging ...

  • Industries : Drug Discovery and Development
  • Countries : Poland
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted

Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted

  • $ 3 500
  • Industry report
  • November 2011
  • by GBI Research

Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted Summary GBI Research, the leading business intelligence provider, has released its ...

  • Industries : Drug Discovery and Development
  • Countries : World
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance Summary GBI Research has released its latest report, ?Post Marketing Clinical ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Japan, Europe, World
Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Drug Discovery and Development
  • Countries : Brazil, India, China, World
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets Summary GBI ...

  • Industries : Drug Discovery and Development
  • Countries : India, China
Pharmaceutical Partnership Deal Terminations

Pharmaceutical Partnership Deal Terminations

  • $ 3 500
  • Industry report
  • September 2011
  • by GBI Research

Pharmaceutical Partnership Deal Terminations Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Pharmaceutical Partnership Deal Terminations? which provides ...

  • Industries : Drug Discovery and Development
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force

Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force

  • $ 3 500
  • Industry report
  • August 2011
  • by GBI Research

Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force Summary GBI Research's report, ?Emerging Pharmaceutical ...

  • Industries : Drug Discovery and Development
  • Countries : India
Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure Summary GBI Research, leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market Summary GBI Research, the leading business ...

  • Industries : Drug Discovery and Development
  • Countries : Brazil
Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player Summary GBI Research has released its latest ...

  • Industries : Drug Discovery and Development
  • Countries : Russian Federation
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development

Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development

  • $ 3 500
  • Industry report
  • July 2011
  • by GBI Research

Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development Summary GBI Research has released its latest report, ?Emerging ...

  • Industries : Drug Discovery and Development
  • Countries : Argentina
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs

Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs

  • $ 3 500
  • Industry report
  • June 2011
  • by GBI Research

Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs Summary GBI Research has released its latest report, ...

  • Industries : Drug Discovery and Development
Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management

  • $ 3 500
  • Industry report
  • June 2011
  • by GBI Research

Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management Summary GBI Research, the leading business intelligence provider, has ...

  • Industries : Drug Discovery and Development
  • Countries : India

1 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.